PsychRounds: The Psychiatry Podcast

Landmark Studies: The CATIE Trial Jul 22, 2026 00:21:53 Today we're starting a new type of series - looking at some of the most seminal studies in psychiatry. We're going to start with the CATIE Trial, which was published in 2005. References: https://www.nejm.org/doi/full/10.1056/NEJMoa051688https://pubmed.ncbi.nlm.nih.gov/19594194/https://pubmed.ncbi.nlm.nih.gov/17924259/https://pubmed.ncbi.nlm.nih.gov/17286522/https://www.nejm.org/doi/full/10

The Rising Use of Recreational Kratom Jul 8, 2026 00:21:13 Apologies for our little hiatus - a couple of us had cross-country moves in June. But we're back! Today we have an episode on the rising use of recreational Kratom and pertinent tidbits to know from a psychiatry standpoint. References:https://pmc.ncbi.nlm.nih.gov/articles/PMC8924421/https://www.ncbi.nlm.nih.gov/books/NBK585120/https://pmc.ncbi.nlm.nih.gov/articles/PMC10846393/https://pmc.ncbi.

Modafinil (Provigil) Jun 3, 2026 00:19:36 Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry.References:Provigil (modafinil) [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/drugsatfdadocs/label/2015/020717s037s038lbl.pdfSchwartz JR. Modafinil in the treatment of excessive sleepiness. Drug Des Deve

Naltrexone May 20, 2026 00:16:10 Welcome Back! Today we are discussing the medication Naltrexone and its uses in psychiatry. References: https://www.ncbi.nlm.nih.gov/books/NBK534811/https://pubmed.ncbi.nlm.nih.gov/24825644/https://pubmed.ncbi.nlm.nih.gov/26798982/https://www.nejm.org/doi/full/10.1056/NEJMct0801733https://pubmed.ncbi.nlm.nih.gov/26798982/

Placebo Effect and Response in Psychiatry May 6, 2026 00:22:14 Welcome back! Today, we will be discussing the placebo effect.References:https://pubmed.ncbi.nlm.nih.gov/16503356/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003660/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556377/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714297/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694178/https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/2018/11

Amantadine (Symmetrel) Apr 8, 2026 00:17:01 Welcome back! Today we are talking all about Amantadine, and it's uses in psychiatry.

VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo) Mar 21, 2026 00:17:19 Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/https://www.ncbi.nlm.nih.gov/books/NBK548187/https://pubmed.ncbi.nlm.nih.gov/41626799/

A DSM Conversation with Dr. Allen Frances Feb 25, 2026 00:55:50 We are back with another special guest episode! Please welcome Dr. Allen Frances, who was intricately involved in the formation of both the DSM III and DSM IV, the latter of which he served as chair.https://x.com/AllenFrancesMDhttps://www.amazon.com/stores/author/B001HO76FUhttps://www.psychiatrictimes.com/authors/allen-frances-md

Topiramate (Topamax) Jan 28, 2026 00:15:19 Welcome back! Today we will be doing a brief episode on Topiramate [Topamax], and its clinical uses in psychiatry.References:https://pubmed.ncbi.nlm.nih.gov/21438989/https://pubmed.ncbi.nlm.nih.gov/18774432/https://pubmed.ncbi.nlm.nih.gov/25899459/https://pmc.ncbi.nlm.nih.gov/articles/PMC1088011/https://pmc.ncbi.nlm.nih.gov/articles/PMC2671954/https://pubmed.ncbi.nlm.nih.gov/38706338/https://pubme

What Makes Something a Psychiatric Illness? Featuring Dr. Mark Ruffalo, MSW, DPsa Jan 14, 2026 00:54:32 Welcome back, today we are discussing a deceptively difficult topic: What makes something a psychiatric illness? We are joined by our guest Dr. Mark Ruffalo. He is a psychotherapist in private practice in Tampa, FL, and who also serves as Assistant Professor of Psychiatry at the University of Central Florida College of Medicine as well an Adjunct Assistant Professor of Psychiatry at Tufts Universi

Lorazepam (Ativan) Dec 31, 2025 00:14:27 Welcome back! Today we are at the highly prescribed and popular benzodiazepine Lorazepam, also known as Ativan. We look at its uses in psychiatry, especially catatonia. But despite anecdotal efficacy, does the evidence hold up? References:https://www.ncbi.nlm.nih.gov/books/NBK532890/https://pubmed.ncbi.nlm.nih.gov/36805317/https://pubmed.ncbi.nlm.nih.gov/6120058/https://pubmed.ncbi.nlm.nih.gov/102

The Vitamin Series: Iron Deficiency in Psychiatry Dec 17, 2025 00:25:24 Welcome back! Today we are embarking into the first of hopefully several episodes on the importance of vitamins and minerals in mental health. We will specifically be looking at the role of iron deficiency in psychiatry and do an overview on some of the recent research that's been published. References: https://www.ncbi.nlm.nih.gov/books/NBK557376/https://www.sciencedirect.com/science/article/

Nutritional Psychiatry with Dr. Laura Lachance Dec 3, 2025 00:49:18 Welcome back! Today our topic is Nutritional Psychiatry and we've invited a special guest - Dr. Laura Lachance, who has done extensive research in the field. Along with Dr. Drew Ramsey, she has published a paper looking at an Antidepressant Food Score or AFS and more recently, she was a part of the EASe-GAD trial, a study looking at the impact of omega-3 fatty acids on anxiety. Antidepressant

Stress, Culture, and Determinism with Dr. Robert Sapolsky Nov 19, 2025 01:03:08 Welcome back! Today, we are hosting the highly accomplished Dr. Robert Sapolsky, PHD, a professor of professor of biology, neurology, and neurosurgery at Stanford University. He has had extensive research particularly in the field of neuroendocrinology and chronic stress, which has acted as one of the foundations of modern psychoneuroendocrinology. He is also a research associate at the Institute

SSRIs Revisited: The 100th Episode Nov 5, 2025 00:32:53 One hundred episodes later, let’s take it back to one of our very first, the Selective Serotonin Reuptake Inhibitors - with a much-needed update. Thank you to our guests, fans, and listeners.References: https://pmc.ncbi.nlm.nih.gov/articles/PMC4428540/ https://pubmed.ncbi.nlm.nih.gov/10333979⁠⁠https://pmc.ncbi.nlm.nih.gov/articles/PMC3663330/⁠

Alprazolam (Xanax) Oct 29, 2025 00:15:00 Welcome back! Today we have a very special episode on Alprazolam, brand-name Xanax. This benzodiazepine is one of the most commonly-prescribed and sought out psychotropic medications. https://www.ncbi.nlm.nih.gov/books/NBK538165/https://pmc.ncbi.nlm.nih.gov/articles/PMC6769182/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5846112/https://pubmed.ncbi.nlm.nih.gov/6141930/https://pubmed.ncbi.nlm.nih.gov/

Climate Change and Mental Health with Dr. Ferdnand Osuagwu Oct 22, 2025 00:34:58 Join us today for an episode on the impact of climate change on mental health. We'll be exploring concepts like eco-anxiety, advocacy, the impact of nuclear war and practical tips. We're joined by guest Dr. Ferdnand Osuagwu, who was the former Chair of the Caucus on Climate Change and Mental Health of the American Psychiatric Association (APA) and founder of the Ferdnand Foundation International,

Introduction to Benzodiazepines Oct 15, 2025 00:22:12 Today, we are talking about a very popular, yet controversial class of medications - the Benzodiazepines . Let's look at their mechanism of action, clinical indications, pharmacology, risks, withdrawal syndromes, and prescribing guidance. And of course, we'll be tackling the question: what are the risks and benefits of long-term use? References: https://pubmed.ncbi.nlm.nih.gov/30098211/htt

Introduction to Anxiety Disorders Oct 8, 2025 00:25:48 Welcome to an introductory episode on anxiety disorders as requested by a long-time listener. References:https://pmc.ncbi.nlm.nih.gov/articles/PMC5832062/https://pmc.ncbi.nlm.nih.gov/articles/PMC5573565/https://deepblue.lib.umich.edu/bitstream/handle/2027.42/175862/Nesse%20Anxiety%20Disorders%20in%20Evolutionary%20Perspective%202022.pdf?sequence=1

Loxapine (Loxitane) Revisited with Dr. Jonathan Meyer Oct 1, 2025 00:24:08 Join us as we talk about Loxapine, an older medication that’s stood the test of time and found a niche in psychiatric practice. This is a revision of an earlier episode, after Dr. Bradley Miller chatted with Dr. Jonathan Meyer at the 2025 APA Conference. Dr. Meyer joins us at the beginning to provide an addendum to the original episode.

Pregabalin (Lyrica) Sep 24, 2025 00:14:20 Welcome back! Today, we will be talking about Pregabalin, brand-name Lyrica, a similar medication to Gabapentin, and we will specifically be focusing on its use in psychiatry. What are its benefits and drawbacks compared to Gabapentin? Sources:- https://pubmed.ncbi.nlm.nih.gov/33563173/- https://pubmed.ncbi.nlm.nih.gov/39989902/- https://pmc.ncbi.nlm.nih.gov/articles/PMC3699256/- https://pubmed.nc

Gabapentin (Neurontin) Sep 17, 2025 00:20:20 Welcome back! Today, we will be talking about Gabapentin, brand-name Neurontin, one of the most commonly-prescribed medications in the United States, and we will specifically be focusing on its use in psychiatry. It is commonly prescribed for anxiety disorders, alcohol use disorder, and sometimes even bipolar disorder! But what does the evidence say?Sources: https://pmc.ncbi.nlm.nih.gov/articles/P

Trauma and The Neurosequential Model of Therapeutics with Dr. Bruce Perry Sep 10, 2025 01:00:30 Welcome back! Today, we have renowned guest Dr. Bruce Perry, one of the world's most influential child psychiatrists, to talk to us about his approach to trauma. We will go over Dr. Perry's Neurosequential Model of Therapeutics, which integrates neuroscience with child development. Dr. Perry is also a respected author, co-writing books like The Boy Who Was Raised As a Dog, Born for Love: Why Empat

The Spectrum of Mood Disorders with Dr. Chris Aiken Sep 3, 2025 00:49:20 Welcome Back! Today we are interviewing Dr. Chris Aiken, Editor-in-Chief of the Carlat Psychiatry Report. We will be speaking about the broad spectrum of mood disorders, how Bipolar Disorder is different from Manic-Depressive Illness, affective temperaments, non-pharmacological treatments, and more! Dr. Aiken's new book, Difficult to Treat Depression, will be released later this year (2025). S

Pramipexole (Mirapex) in Treatment Resistant Depression Aug 27, 2025 00:26:21 Welcome back! Today, we will review Pramipexole (Mirapex) and take a look at a recent study published in The Lancet Psychiatry regarding its use in treatment-resistant depression.References:https://pubmed.ncbi.nlm.nih.gov/17854248/https://pmc.ncbi.nlm.nih.gov/articles/PMC10034846/https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00194-4/fulltext

Psychedelics, Consciousness, and Buddhist Practices with Dr. Charles Raison Aug 20, 2025 01:01:01 Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today's episode is with Dr. Charles Raison, a psychiatrist. This is the second part of our discussion, and we’re going to be looking at novel treatments like psychedelics and their impact on consciousness as well as whole-body hyperthermia and practices fro

The Biological and Evolutionary Underpinnings of Depression with Dr. Charles Raison Aug 13, 2025 00:46:33 Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today's episode is with Dr. Charles Raison, a psychiatrist who has done extensive research on the biological and evolutionary underpinnings of depression, which includes inflammation and the neuroendocrine system. Dr. Raison co-authored the 2017 book The Ne

Monitoring Antipsychotic Plasma Levels with Dr. Jonathan Meyer Aug 6, 2025 00:32:19 Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today is the second installment of this endeavor, featuring Dr. Jonathan Meyer on the topic of Antipsychotic plasma level monitoring. Dr. Meyer has authored the handbook on this topic, along with the Lithium and Clozapine handbooks as well. You can find the

Positive Psychiatry with Dr. Rakesh Jain Jul 30, 2025 01:05:49 Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today we will be speaking to the distinguished Dr. Rakesh Jain on the topic of Positive Psychiatry. Psych Congress Discount Code: PSYCHROUNDSConference Website: https://www.hmpglobalevents.com/psych-congressCheck out Dr. Jain’s podcast “Positive Psychiatry

The Anxiolytics: Propranolol (Inderal) Jul 16, 2025 00:14:00 Welcome back! Today we are looking at the beta-blocker Propranolol, also known by its brand name, Inderal. Although this medication is sometimes used as an anti-hypertensive, we are going to look at its use in psychiatry and anxiety disorders. Sourceshttps://www.ncbi.nlm.nih.gov/books/NBK562942/https://pubmed.ncbi.nlm.nih.gov/32001828/https://pmc.ncbi.nlm.nih.gov/articles/PMC4724794/https://pubmed

The Anxiolytics: Buspirone (Buspar) Jul 2, 2025 00:12:43 On today's episode, we will be discussing Buspirone (Buspar), a commonly used medication for anxiety.References:https://www.sciencedirect.com/science/article/pii/S2405844024049491https://pubmed.ncbi.nlm.nih.gov/3041384/https://www.ncbi.nlm.nih.gov/books/NBK531477/https://pubmed.ncbi.nlm.nih.gov/39493804/https://pubmed.ncbi.nlm.nih.gov/22998742/

Cultural Psychiatry with Dr. Francis Lu Jun 18, 2025 00:31:18 Today, we have one of the giants and pioneers of Asian-American Psychiatry joining us to discuss Cultural Psychiatry, Dr. Francis Lu! Dr. Lu's Books: https://www.amazon.com/stores/author/B003HFAX8E?ccs_id=d6d03eae-2c95-481f-8f7a-f844580eb108References:https://psychiatryonline.org/doi/10.1176/appi.focus.18103https://psycnet.apa.org/record/2015-37696-000

The Anxiolytics: Hydroxyzine (Atarax/Vistaril) Jun 11, 2025 00:16:40 Welcome back! On todays episode, we will discuss hydroxyzine (Atarax, Vistaril), a frequently used medication for anxiety.References:https://pubmed.ncbi.nlm.nih.gov/9616188/https://pubmed.ncbi.nlm.nih.gov/27998379/https://pubmed.ncbi.nlm.nih.gov/21154375/https://pubmed.ncbi.nlm.nih.gov/1345410/

Introduction to Metabolic Psychiatry with Dr. Matthew Bernstein Jun 4, 2025 01:06:36 We're back from our brief hiatus! Today, we are hosting Dr. Matthew Bernstein to talk about a rising subfield of psychiatry - Metabolic Psychiatry. We'll be looking at its history, the ketogenic diet, mitochondria, and more! References- https://pubmed.ncbi.nlm.nih.gov/38273108/- https://pubmed.ncbi.nlm.nih.gov/34113269/- https://pubmed.ncbi.nlm.nih.gov/39296512/- https://pmc.ncbi.nlm.nih.gov/artic

The Salience Network May 21, 2025 00:16:12 Welcome to today's episode on the salience network, the final episode in our three-part series on neural networks. We'll explore how the salience network helps the brain prioritize what matters most by filtering relevant stimuli.References:https://pmc.ncbi.nlm.nih.gov/articles/PMC2899886/https://www.nature.com/articles/s41398-018-0118-6https://www.nature.com/articles/s41598-022-15489-9http

Transcranial Magnetic Stimulation/TMS [ONE-D / THREE-D Trials] with Dr. Jonathan Downar May 14, 2025 00:59:51 On todays episode we will be discussing Transcranial Magnetic Stimulation with a very special guest, Dr. Jonathan Downar. We will also discuss the ONE-D and THREE-D trails.Three-D Trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30295-2/abstract’One-D Trial: https://www.researchsquare.com/article/rs-5679327/v1SAINT TMS: https://psychiatryonline.org/doi/10.1176/appi.ajp.201

The Central Executive Network (CEN) May 7, 2025 00:13:45 On today's episode, we continue our series with a discussion of the Central Executive Network, following our previous episode on the Default Mode Network.References: https://pubmed.ncbi.nlm.nih.gov/30250390/https://pmc.ncbi.nlm.nih.gov/articles/PMC4162869/https://link.springer.com/article/10.3758/s13415-011-0083-5https://www.cell.com/neuron/comments/S0896-6273(06)00349-7https://pubmed.ncbi.nlm.nih

Electroconvulsive Therapy/ECT [KetECT/ELEKT-D] with Dr. Pouya Movahed Rad Apr 30, 2025 00:43:22 On today's episode we have a special international guest, Dr. Pouya Movahed Rad from Lund University in Sweden. We will be discussing Electroconvulsive therapy (ECT) and the Ket-ECT, and ELEKT-D studies. ELEKTD:https://www.nejm.org/doi/full/10.1056/NEJMoa2302399KET-ECT: https://pubmed.ncbi.nlm.nih.gov/35020871/Comparison: https://pubmed.ncbi.nlm.nih.gov/38114073/

The Default Mode Network Apr 23, 2025 00:23:02 Join us today as we venture into the Triple Network Model as a basis for psychiatric illness, starting with the Default Mode Network. Referenceshttps://pmc.ncbi.nlm.nih.gov/articles/PMC7959111/https://pubmed.ncbi.nlm.nih.gov/37167968/https://www.nature.com/articles/s42003-019-0611-3https://www.psychiatrictimes.com/view/mindwandering-mood-for-thoughthttps://www.nature.com/articles/s41380-021-01403-

Metformin: Use in Psychiatry and New Guidelines Apr 16, 2025 00:18:00 Welcome back! Today we will be discussing Metformin and some of the recent guidelines published in the journal the Schizophrenia Bulletin. (Carolan et. al 2024).

Nitrous Oxide for Treatment-Resistant Depression with Dr. Charles Conway and Dr. Vasilis Hristidis Apr 9, 2025 00:40:30 On today’s special guest episode, we’ll be exploring the topic of nitrous oxide with Dr. Charles Conway and Dr. Vasilis Hristidis.https://medicine.washu.edu/news/laughing-gas-relieves-symptoms-in-people-with-treatment-resistant-depression/https://pmc.ncbi.nlm.nih.gov/articles/PMC5825282/https://pubmed.ncbi.nlm.nih.gov/34108247/https://pubmed.ncbi.nlm.nih.gov/25577164/

Ketamine/Esketamine (Spravato) with Dr. Joshua Rosenblat Apr 1, 2025 00:35:38 In today’s episode, we explore ketamine’s therapeutic potential with Dr. Joshua Rosenblat, a leading expert and faculty member at the University of Toronto’s Department of Psychiatry (learn more). https://x.com/jd_rosenblat?lang=enhttps://pubmed.ncbi.nlm.nih.gov/35688035/https://pubmed.ncbi.nlm.nih.gov/39608193/

Auvelity (Bupropion/Dextromethorphan) Mar 26, 2025 00:19:37 Welcome back! Today, we are discussing a new branded medication that combines bupropion with dextromethorphan for the treatment of depression.

The Tricyclic Antidepressants (TCAs) Mar 19, 2025 00:20:26 Today, we will be discussing tricyclic antidepressants (TCA's). Once again, we've picked a few of our favorites to discuss on today's episode.

The Monoamine Oxidase Inhibitors (MAOI's) Mar 12, 2025 00:24:14 Welcome back! Today, we will be discussing MAOIs, and we've picked out a few of our favorites for today's episode.

Depression and Inflammation: An Evolutionary Perspective Mar 5, 2025 00:22:17 Could there be an evolutionary perspective for depression? Join us for part two of our series on depression and inflammation.

Depression and Inflammation: An Introduction Feb 26, 2025 00:18:24 Join us as we talk about the relationship between depression and inflammation - an interesting biological theory.

Mitigating Antipsychotic-Induced Weight Gain Feb 12, 2025 00:38:32 Welcome back! Today, we have a special guest-episode with a senior medical student, Jun-Hwan Kim. Join us as we talk about anti-psychotic associated weight gain.

Clozapine (Clozaril) with Dr. John Kane Feb 5, 2025 00:39:48 Today, we have a very special guest joining us—Dr. John Kane! We will be discussing his experience and history with clozapine, a groundbreaking medication for treatment-resistant schizophrenia.

The Antipsychotics: Lumateperone (Caplyta) Jan 29, 2025 00:12:41 Join us and we discuss a newer anti-psychotic medication, Lumateperone, brand name Caplyta.

The Antipsychotics: Cariprazine (Vraylar) Jan 22, 2025 00:13:06 Welcome back to our final partial agonist episode! Today we are discussing Cariprazine, brand name, Vraylar.

The Antipsychotics: Brexpiprazole (Rexulti) Jan 15, 2025 00:12:31 Welcome back! Brexpiprazole, also known by its brand name Rexulti, is a relatively new medication. Join us for a brief discussion.

The Antipsychotics: Aripiprazole (Abilify) Jan 8, 2025 00:26:31 Welcome back! Today we are talking about Aripiprazole, brand name Abilify.

The Antipsychotics: Quetiapine (Seroquel) Jan 1, 2025 00:26:07 Welcome back and Happy New Year! Today, we are kicking it off with a brief episode on Quetiapine (Seroquel).

The Antipsychotics: Asenapine (Saphris) Dec 18, 2024 00:11:55 Welcome back! Today, we have a short-episode on a unique second generation anti-psychotic, Asenapine (Saphris, Secuado).

Extrapyramidal Symptoms (EPS) Dec 11, 2024 00:21:46 Welcome back, on today's episode we will briefly go over the extrapyramidal symptoms associated with anti-psychotics.

The Antipsychotics: Olanzapine-Fluoxetine (Symbyax) Dec 4, 2024 00:22:02 Dr. Larry Wang will be hosting todays episode with a very special guest. . . another Dr. Larry Wang? . . . Bipolar depression being treated with an antidepressant? Welcome to the multiverse.

The Antipsychotics: Olanzapine (Zyprexa) Nov 27, 2024 00:23:02 Welcome back to our antipsychotic series. Today, we will be discussing Olanzapine, brand-name, Zyprexa.

Suicide Prevention with Dr. Christine Yu Moutier, M.D. Nov 20, 2024 01:07:14 Welcome to another special guest episode. In this episode, we are joined by Dr. Christine Yu Moutier, M.D., the acting Chief Medical Officer of the American Foundation for Suicide Prevention. We’ll be discussing important topics around suicide prevention and much more. AFSP: ⁠https://afsp.org/⁠ Suicide Prevention Handbook: https://www.cambridge.org/core/books/suicide-prevention/8BE216EF6EF05ABAF8

The Sleep Series: Cognitive Behavioral Therapy for Insomnia (CBT-I) Nov 13, 2024 00:29:19 Join us as we take a break from some psychopharmacology. Today, we will be talking about CBT-I, one of the first-line therapy interventions for insomnia.

The Sleep Series: Melatonin and Ramelteon (Rozerem) Nov 6, 2024 00:17:54 Welcome back to our sleep series! Today, we're diving into two of the most popular sleep aids: Melatonin and Rozerem.

The Sleep Series: Orexin Antagonists (Suvorexant, Lemborexant, Daridorexant) Oct 30, 2024 00:15:44 Join us for our first episode on the orexin antagonists! We will be briefly discussing: Suvorexant, brand-name Belsomra, Lemborexant, brand-name Dayvigo, and Daridorexant, brand-name Quviviq. https://www.sciencedirect.com/science/article/pii/S0165032724019876?via%3Dihub

The Sleep Series: Z Drugs (Zolpidem, Zaleplon, EsZopiclone) Oct 23, 2024 00:17:10 In this episode, we explore the Z Drugs—Zolpidem, Zaleplon, and Eszopiclone. Join us as we give a brief introduction to this class of medications commonly used for sleep. ANSWER TO POLL QUESTION BELOW (SPOILER) —————————————————— Answer: Choice B (Zolpidem)

The Sleep Series: H1 Antagonists (Trazodone, Benadryl, Doxepin) Oct 16, 2024 00:19:16 Join us as we discuss a commonly used class of medications for sleep, the H1 antagonists. This includes medications such as hydroxyzine, mirtazapine, doxepin and more Answer to Poll Question Below (SPOILER) —————————————————— Answer: Choice B (Doxepin)

Sleep Medicine in Psychiatry with Dr. Barry Krakow Oct 9, 2024 01:00:53 Welcome to our next guest episode! We’re excited to have Dr. Barry Krakow, M.D., with us. In this episode, he’ll provide an introduction to sleep medicine in psychiatry. Be sure to check out his website below: https://barrykrakowmd.com/ Answer to Poll Question Below (SPOILER) ----------------------------------------------------------------- Answer: E (Priapism)

The Antipsychotics: Lurasidone (Latuda) Oct 2, 2024 00:17:21 Did someone say Latuda Lafooda? Join us as we talk about a frequently used anti-psychotic that recently went generic. Answer to Poll Question Below (SPOILER) ----------------------------------------------------------------- Answer: D (CYP 3A4)

The Antipsychotics: Ziprasidone (Geodon) Sep 25, 2024 00:14:42 On this episode we will be talking about another atypical antipsychotic, Geodon (Ziprasidone). Answer to Poll Question Below (SPOILER) ----------------------------------------------------------------- Answer: C (Akathsia)

The Antipsychotics: Paliperidone (Invega) Sep 18, 2024 00:14:49 Join us as we discuss Invega (Paliperidone) and its various long-acting formulations such as Sustenna, Trinza, and Hafyera. Help us decide what topics do next! Poll below!

The Antipsychotics: Risperidone (Risperdal) Sep 11, 2024 00:18:56 Join us as we discuss a second generation antipsychotic, Risperidone (Risperdal). We will also cover some the long-acting injectable formulations such as Consta, Uzedy and Perseris. Answer to Poll Question Below (SPOILER) ----------------------------------------------------------------- Answer: D (Low-dose Aripiprazole)

The Antipsychotics: Fluphenazine (Prolixin) Sep 4, 2024 00:14:00 Join us as we discuss another typical antipsychotic, Fluphenazine (Prolixin). Answer to Poll Question Below (SPOILER) ----------------------------------------------------------- Answer: B (1.25)

The Antipsychotics: Haloperidol (Haldol) Aug 28, 2024 00:21:08 Today, we will be discussing one of the most commonly used first generation anti-psychotics, Haloperidol (Haldol). Answer to Poll Question Below (SPOILER) —————————————————— Answer: Choice C (Fluphenazine)

The Antipsychotics: Chlorpromazine (Thorazine) Aug 21, 2024 00:16:41 Join us as we start off the anti-psychotic series! Today, we will discuss the very first antipsychotic brought to market in the United States, Thorazine (Chlorpromazine). Answer to Poll Question Below (SPOILER) ------------------------------------------------------ Answer: D (Hiccups)

Schizophrenia: Antipsychotics with Dr. Jason Cafer Aug 14, 2024 00:56:42 Join us and special guest Dr. Jason Cafer, author of Cafer's Psychopharmacology, for a Q&A on antipsychotics and schizophrenia. For more information visit: https://www.cafermed.com/ Answer to poll question below (SPOILER) ————————————————— Answer: Option B: B Vitamins.

Schizophrenia: Pathophysiology and Receptors of Interest Aug 7, 2024 00:16:58 Join us for the second episode of our Schizophrenia series. Today, we will be discussing the pathophysiology and some of the receptors of interest in this disorder.

Schizophrenia: Introduction, History and Diagnosis Jul 31, 2024 00:25:35 Welcome to our first episode on Schizophrenia! We will be talking about diagnosis, history, treatment, and much more on this mini-series.

Mood Stabilizers: Carbamazepine (Tegretol) and Oxcarbazepine (Trileptal) Jul 24, 2024 00:18:53 On this episode, we will discuss two additional mood stabilizers Carbamazepine (Tegretol) and it's cousin Oxcarbazepine (Trileptal).

Mood Stabilizers: Lamotrigine (Lamictal) Jul 17, 2024 00:22:57 Welcome to today's episode where we discuss another mood stabilizer, Lamotrigine (Lamictal).

Mood Stabilizers: Valproic Acid (Depakote) Jul 10, 2024 00:26:05 Welcome to our next mood stabilizer episode, today we will be discussing Valproic Acid! Other medication names you may encounter: Depakote DR, ER, and Depakene.

Delirium with Dr. Lorrie Garces Jul 4, 2024 00:35:08 What is Delirium? Join us for a special guest episode with Dr. Lorrie Garces MD, a consultation liaison psychiatrist.

Transitioning to Psychiatry Residency: Insights & Resources Jun 28, 2024 00:39:25 Are you a medical student, resident, psychiatric nurse practitioner, or PA? Join us as we highlight some of our favorite resources for starting psychiatric training. We'll also share tips to help incoming residents.

Episodes

Recommended